ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation (Q36578386)

15 August 2017

1 reference

title

ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation (English)

1 reference

blood group incompatibility

15 August 2017

organ transplantation

1 reference

based on heuristic

inferred from title

1 reference

4

Jörg D Seebach

1 reference

15 August 2017

Georg Stussi

1

1 reference

PubMed ID

16935028

15 August 2017

Jörg Halter

series ordinal

2

1 reference

PubMed ID

16935028

15 August 2017

Urs Schanz

series ordinal

3

1 reference

15 August 2017

28 August 2006

1 reference

Transfusion and Apheresis Science

15 August 2017

1 reference

15 August 2017

35

1 reference

15 August 2017

1

1 reference

15 August 2017

59-69

1 reference

Immunobiology of acute graft-versus-host disease

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Antigen presentation in graft-vs-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

ABO blood group barrier in allogeneic bone marrow transplantation revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Immune hemolysis associated with transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Positive antiglobulin tests due to intravenous immunoglobulin in patients who received bone marrow transplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

ABO-incompatible marrow transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Immunoadsorption for removal of A and B blood-group antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

ABO-incompatible bone-marrow transplantation: removal of red blood cells from donor marrow avoiding recipient antibody depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

ABH incompatible bone marrow transplantation: removal of erythrocytes by starch sedimentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Processing of major ABO-incompatible bone marrow for transplantation by using dextran sedimentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Rapid engraftment after allogeneic ABO-incompatible peripheral blood progenitor cell transplantation complicated by severe hemolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Immunohematologic consequences of major ABO-mismatched bone marrow transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Is the ABO incompatibility a risk factor in bone marrow transplantation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Levels of anti-A/B antibodies after ABO-incompatible hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

CD34+-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Apheresis therapy for prolonged red cell aplasia after major ABO-mismatched bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

The second century of ABO: and now for something completely different.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

ABH antigens and bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Long-term results of ABO-incompatible living kidney transplantation: a single-center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Long-term follow-up of ABO-incompatible renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: survey of 101 cases to determine whether splenectomies are necessary for successful transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

ABO-incompatible living-donor kidney transplantation in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Plasma exchange conditioning for ABO-incompatible renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

ABO-incompatible kidney transplantation using both A2 and non-A2 living donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Baboon-to-human cardiac xenotransplantation in a neonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

ABO-incompatible heart transplantation in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Abo-incompatible heart transplantation in infants: the Freeman Hospital experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Successful ABO-incompatible heart transplantation in two infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Pediatric heart transplantation across ABO blood type barriers: a case study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Histo-blood group type change of the graft from B to O after ABO mismatched heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Management of an ABO-incompatible lung transplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Swiss hospital investigates heart transplant "experiment"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Tolerance induction in clinical transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

B-cell tolerance following ABO-incompatible infant heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Chimerism of the transplanted heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Endothelial cell chimerism after renal transplantation and vascular rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Transplanted bone marrow generates new neurons in human brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

Little evidence of donor-derived epithelial cells in early digestive acute graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.009

10.1016/J.TRANSCI.2006.05.009

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16935028